Member Exclusive Interview

Targeted protein degradation: an interview with Ian Collins

In this interview with Ian Collins (The Institute of Cancer Research; London UK) learn more about PROTACs – Proteolysis Targeting Chimeras – a potential alternative to small molecule inhibitors. What are they? How do they work? What impact could they have on drug discovery?

Apr 01, 2019

Please sign in or register for FREE

No comments yet.